27 research outputs found

    CENTRO DE PARTO NORMAL COMO ESTRATÉGIA DE INCENTIVO AO PARTO NORMAL: ESTUDO DESCRITIVO

    Get PDF
    Recientemente se verificó un esfuerzo gubernamental para reducir las tasas de cesariana en el sector público y cualificar la asistencia al parto normal. Así, se crearon los Centros de Parto Normal (CPN) destinados al acompañamiento de nacimientos fisiológicos, a cargo de enfermeras obstétricas. Este estudio descriptivo tuvo como objetivo caracterizar a las parturientas en cuanto a la edad materna, historia obstétrica, condiciones del parto y del recién-nacido en un CPN, en la ciudad de São Paulo. Se utilizaron datos secundarios de registros de nacimientos atendidos por enfermeras obstétricas y se analizaron 1.860 registros de partos ocurridos en julio y agosto de 2001. Los resultados indican: edad media de 23,7 años; 44,4% de nulíparas; 79,0% de partos normales; peso medio de los recién-nacidos de 3.174g; Apgar ≥7 en el primer y quinto minutos en 93,7% y 99,1% de los recién nacidos, respectivamente. Se concluyó que la atención al parto hecha por enfermeras obstétricas es importante para valorar la fisiología del parto y nacimiento, con indicadores obstétricos y neonatales de calidad.Tem-se verificado um esforço governamental para reduzir as taxas de cesariana no setor público e qualificar a assistência ao parto normal. Assim, foram criados Centros de Parto Normal (CPN) destinados ao acompanhamento de nascimentos fisiológicos, a cargo de enfermeiras obstétricas. Este estudo descritivo teve como objetivo caracterizar as parturientes quanto à idade materna, história obstétrica, condições do parto e do recémnascido em um CPN, na cidade de São Paulo. Utilizaram-se dados secundários de registros de nascimentos assistidos por enfermeiras obstétricas. Foram analisados 1.860 registros de partos ocorridos em julho e agosto de 2001. Os resultados indicam: idade média de 23,7 anos; 44,4% de nulíparas; 79,0% de partos normais; peso médio dos recém-nascidos de 3.174 g; índice de Apgar ≥7 no primeiro e quinto minutos em 93,7% e 99,1% dos recémnascidos, respectivamente. Concluiu-se que a assistência prestada por enfermeiras obstétricas em CPN vai ir ao encontro da valorização da fisiologia do parto e nascimento, com indicadores neonatais e obstétricos de qualidade

    Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries : Analysis from the RIETE registry

    Get PDF
    publishersversionPeer reviewe

    MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN

    No full text
    Recent studies have shown that miR-146b is the most upregulated microRNA in thyroid cancer and has a central role in cancer progression through mechanisms that remain largely unidentified. As phosphoinositide 3-kinase/protein kinase-B (PI3K/AKT) signaling is a fundamental oncogenic driver in many thyroid cancers, we explored a potential role for miR-146b and its target genes in PI3K/AKT activation. Among the predicted target genes of miR-146b, we found the tumor-suppressor phosphatase and tensin homolog (PTEN). Constitutive overexpression of miR-146b in thyroid epithelial cell lines significantly decreased PTEN mRNA and protein levels by direct binding to its 3'-UTR. This was accompanied by PI3K/AKT hyperactivation, leading to the exclusion of FOXO1 and p27 from the nucleus and a corresponding increase in cellular proliferation. Moreover, miR-146b overexpression led to protection from apoptosis and an increased migration and invasion potential, regulating genes involved in epithelial-mesenchymal transition. Notably, with the single exception of E-cadherin expression, all of these outcomes could be reversed by PTEN coexpression. Further analysis showed that miR-146b directly inhibits E-cadherin expression through binding to its 3'-UTR. Interestingly, miR-146b inhibition in human thyroid tumor xenografts, using a synthetic and clinically amenable molecule, blocked tumor growth when delivered intratumorally. Importantly, this inhibition increased PTEN protein levels. In conclusion, our data define a novel mechanism of PI3K/AKT hyperactivation and outline a regulatory role for miR-146b in suppressing PTEN expression, a frequent observation in thyroid cancer. Both events are related to a more aggressive tumoral phenotype. Targeting miR-146b therefore represents a promising therapeutic strategy for the treatment of this disease.This work was supported by grants SAF2013-44709-R and SAF2016-75531-R from the Ministerio de Economía y Competitividad (MINECO) of Spain, RD12/0036/0030 from Instituto de Salud Carlos III (ISCIII), Fondo Europeo de Desarrollo Regional (FEDER), and GCB14142311CRES from Fundación Española contra el Cancer. JR-M holds a FPU fellowship from Ministerio de Educación Cultura y Deporte. LW-L was funded by an FPI fellowship from MEC and is currently an investigator of the project PI14/01980 from ISCIII (Spain).Peer reviewe
    corecore